Showing results (31-40 of 633) with videos related to
Sort By:
Pageof 64
Nature Reviews. Neurology|April 13, 2023
Bruton tyrosine kinase inhibitors for multiple sclerosisJulia Krämer, Amit Bar-Or, Timothy J Turner, et al.Archives of Neurology|December 15, 2010
Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosisTrina A Johnson, Yves Lapierre, Amit Bar-Or, et al.The Lancet. Neurology|September 22, 2007
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directionsBrenda Banwell, Angelo Ghezzi, Amit Bar-Or, et al.Frontiers in Immunology|January 22, 2016
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS AutoimmunityNatalia B Pikor, Alexandre Prat, Amit Bar-Or, et al.Journal of Immunological Methods|August 25, 2012
A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samplesChahrazed Belabani, Sathyanath Rajasekharan, Viviane Poupon, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 18, 2025
Exploring the Clinical Utility of Neurofilament Light Chain Assays in Multiple Sclerosis ManagementAmit Bar-Or, Jacqueline Nicholas, Jenny Feng, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Patient and community preferences for treatments and health states in multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.Neuroimmunology and Neuroinflammation|July 31, 2025
Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosisLeah R Zuroff, Joyce A Benjamins, Amit Bar-Or, et al.Nature Reviews. Neurology|January 13, 2011
Therapies for multiple sclerosis: considerations in the pediatric patientBrenda Banwell, Amit Bar-Or, Gavin Giovannoni, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.Pageof 64